QDEL Quidel Corp
Price (delayed)
$25.73
Market cap
$1.74B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$30.54
Enterprise value
$4.29B
Quidel Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide. On May 8, 2020 the U.S. Food and Drug Administration has issued the first emergency
Highlights
QDEL's debt is down by 2.7% from the previous quarter but it is up by 2.4% YoY
The equity has contracted by 40% YoY and by 6% from the previous quarter
QDEL's quick ratio is down by 32% YoY and by 12% from the previous quarter
Key stats
What are the main financial stats of QDEL
Market
Valuations
Earnings
Shares outstanding
67.45M
Market cap
$1.74B
Enterprise value
$4.29B
Price to earnings (P/E)
N/A
Price to book (P/B)
0.58
Price to sales (P/S)
0.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.54
Revenue
$2.78B
Gross profit
$1.29B
Operating income
-$1.96B
Net income
-$2.05B
EBIT
-$1.97B
EBITDA
-$1.51B
Free cash flow
-$112.1M
Per share
Balance sheet
Liquidity
EPS
-$30.54
EPS diluted
-$30.54
Free cash flow per share
-$1.67
Book value per share
$44.37
Revenue per share
$41.41
TBVPS
$45.22
Total assets
$6.42B
Total liabilities
$3.44B
Debt
$2.65B
Equity
$2.98B
Working capital
$220.1M
Debt to equity
0.89
Current ratio
1.22
Quick ratio
0.38
Net debt/EBITDA
-1.68
Margins
Efficiency
Dividend
EBITDA margin
-54.4%
Gross margin
46.2%
Net margin
-73.7%
Operating margin
-70.5%
Return on assets
-30.8%
Return on equity
-64.9%
Return on invested capital
-41.4%
Return on capital employed
-36.3%
Return on sales
-70.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
QDEL stock price
How has the Quidel stock price performed over time
Intraday
5.19%
1 week
1.82%
1 month
-28.39%
1 year
-36.31%
YTD
-42.24%
QTD
-26.42%
Financial performance
How have Quidel's revenue and profit performed over time
Revenue
$2.78B
Gross profit
$1.29B
Operating income
-$1.96B
Net income
-$2.05B
Gross margin
46.2%
Net margin
-73.7%
Quidel's gross profit has decreased by 14% YoY and by 4.2% QoQ
QDEL's net margin is down by 11% from the previous quarter
The net income has declined by 10% since the previous quarter
Quidel's operating margin has decreased by 9% from the previous quarter
Growth
What is Quidel's growth rate over time
Valuation
What is Quidel stock price valuation
P/E
N/A
P/B
0.58
P/S
0.62
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.54
The company's EPS fell by 10% QoQ
The stock's price to book (P/B) is 81% less than its 5-year quarterly average of 3.1 and 36% less than its last 4 quarters average of 0.9
The equity has contracted by 40% YoY and by 6% from the previous quarter
QDEL's P/S is 80% below its 5-year quarterly average of 3.1 and 38% below its last 4 quarters average of 1.0
QDEL's revenue is down by 7% year-on-year
Efficiency
How efficient is Quidel business performance
Quidel's return on equity has decreased by 28% QoQ
QDEL's return on assets is down by 18% since the previous quarter
QDEL's return on invested capital is down by 8% since the previous quarter
The company's return on sales fell by 8% QoQ
Dividends
What is QDEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for QDEL.
Financial health
How did Quidel financials performed over time
QDEL's total assets is 87% greater than its total liabilities
QDEL's quick ratio is down by 32% YoY and by 12% from the previous quarter
QDEL's total assets is down by 25% year-on-year and by 6% since the previous quarter
QDEL's debt is 11% less than its equity
The debt to equity has surged by 71% year-on-year and by 4.7% since the previous quarter
The equity has contracted by 40% YoY and by 6% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.